Who Exports Loratadine from India — 347 Suppliers Behind a $173.1M Market
India's loratadine export market is supplied by 347 active exporters who collectively shipped $173.1M across 4,321 shipments. SANDOZ PRIVATE LIMITED leads with a 60.7% market share, followed by AUROBINDO PHARMA LTD and MARKSANS PHARMA LIMITED. The top 5 suppliers together control 76.4% of total export value, reflecting a concentrated market structure.
Top Loratadine Exporters from India — Ranked by Export Value
SANDOZ PRIVATE LIMITED is the leading loratadine exporter from India, holding a 60.7% share of the $173.1M market across 4,321 shipments from 347 exporters. The top 5 suppliers — SANDOZ PRIVATE LIMITED, AUROBINDO PHARMA LTD, MARKSANS PHARMA LIMITED, GRANULES INDIA LIMITED, WEXFORD LABORATORIES PRIVATE LIMITED — collectively control 76.4% of total export value, indicating a highly concentrated market. Individual shares are: SANDOZ PRIVATE LIMITED (60.7%), AUROBINDO PHARMA LTD (6.3%), MARKSANS PHARMA LIMITED (4.6%), GRANULES INDIA LIMITED (2.5%), WEXFORD LABORATORIES PRIVATE LIMITED (2.3%).
Top Loratadine Exporters from India
Ranked by export value · 347 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | SANDOZ PRIVATE LIMITED DESLORATADINE FCT 5MG IN91 SH EU 07 MATERIAL NO. - 42031824DESLORATADINE FCT 5MG IN91 SH EU 07 MATEMATERIAL NO. - 42031824 DESLORATADINE FCT 5MG IN91 SH EU 07 | $105.1M | 5 | 60.7% |
| 2 | AUROBINDO PHARMA LTD DESLORATADINE TABLETS 5 MG(DESLORATADINADESLORATADINE TABLETS 5 MG(DESLORATADINEDESLORATADINE TABLETS 5 MG(DESLORATIDIN | $10.8M | 5 | 6.3% |
| 3 | MARKSANS PHARMA LIMITED LORATADINE USP 10MG 100TABS USA EXPLORATADINE TABLETS USP 10MGPHARMACEUTICAL PRODUCTS-LORATADINE 10MG | $7.9M | 6 | 4.6% |
| 4 | GRANULES INDIA LIMITED LORATADINE USP 10MG 100TABS USA EXPLORATADINE TABLETS USP 10MGDESLORATADINE TABLETS USP 5 MG -43536 BTL X 100 TABS | $4.3M | 1 | 2.5% |
| 5 | WEXFORD LABORATORIES PRIVATE LIMITED LORATADINE TABLETS USP 10MGLORATADINE ORAL SUSPENSION USP 5MG/5ML-1LORATADINE ORAL SOLUTION USP 5MG/5ML - 100MLNOS | $4.0M | 5 | 2.3% |
| 6 | MYLAN LABORATORIES LIMITED LORATADINE USP 10MG 100TABS USA EXPLORATADINE TABLETS USP 10MGDESLORATADINE TAB 5MG EU | $2.8M | 4 | 1.6% |
| 7 | LUPIN LIMITED LORATADINE USP 10MG 100TABS USA EXPLORATADINE TABLETS USP 10MGDESLORATADINE TABLETS USP 5 MG -43536 BTL X 100 TABS | $2.7M | 1 | 1.6% |
| 8 | J B CHEMICALS AND PHARMACEUTICALS LIMITED LORATADINE USP 10MG 100TABS USA EXPLORATADINE TABLETS USP 10MGDESLORATADINA 5 MG (DESLORATADINE 5 MG T | $2.6M | 2 | 1.5% |
| 9 | SUN PHARMACEUTICAL INDUSTRIES LIMITED DAZIT TABS EACH TAB CONTAINS : DESLORATADINE 5MG | $2.4M | 9 | 1.4% |
| 10 | MEDREICH LIMITED PHARMACEUTICAL PRODUCTS-LORATADINE 10MGTRUST LORATADINE ANTIHISTA 10MG TABLET [3990 PACK X10X10'S]LORATADINE 10MG TABLETS (DEMAZIN ALLERG | $2.3M | 7 | 1.3% |
| 11 | IND SWIFT LIMITED LORATADINE TABLETS USP 10MGDESLORATADINE TABLETS 5 MG(DESLORATADINADESLORATADINE TABLETS 5 MG(DESLORATADINE | $2.0M | 5 | 1.2% |
| 12 | CAPLIN POINT LABORATORIES LIMITED LORATADINE TABLETS USP 10MGLORATADINE ORAL SUSPENSION USP 5MG/5ML-1DESLORATADINA 5 MG (DESLORATADINE 5 MG T | $1.5M | 7 | 0.9% |
| 13 | ZYDUS LIFESCIENCES LIMITED DESLORATADINE TAB 5MG EUHARMLESS MEDICINES, DESLORATADINE TABLETS 5 MGDESLORATADINE TABLETS 5 MG(DESLORATADINE | $1.5M | 13 | 0.8% |
| 14 | DR.REDDY'S LABORATORIES LTD LORATADINE USP 10MG 100TABS USA EXPLORATADINE TABLETS USP 10MGDESLORATADINE TABLETS USP 5 MG -43536 BTL X 100 TABS | $1.3M | 1 | 0.8% |
| 15 | ALKEM LABORATORIES LIMITED DESLORATADINA 5 MG (DESLORATADINE 5 MG TTRUST LORATADINE ANTIHISTA 10MG TABLET [3990 PACK X10X10'S]LORATADINE 10MG TABLETS (DEMAZIN ALLERG | $1.1M | 2 | 0.7% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Loratadine exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Aurobindo Pharma Limited | Approved | Yes | Yes | 41 (January 2023 to September 2023) | Received FDA approval for Vancomycin Hydrochloride for Injection in August 2023. |
| Granules India Limited | Approved | Yes | Yes | 9 (January 2023 to September 2023) | Received positive USFDA Establishment Inspection Report for its Virginia facilit |
| Lupin Limited | Approved | Yes | Yes | 15 (January 2023 to September 2023) | Received FDA approval for Raltegravir Tablets USP, 600 mg in May 2025. |
| Zydus Lifesciences Limited | Approved | Yes | Yes | 59 (January 2023 to September 2023) | Achieved successful USFDA pre-approval inspection at Ahmedabad facility. |
| Dr. Reddy's Laboratories Ltd | Approved | Yes | Yes | 7 (January 2023 to September 2023) | Received FDA approval for multiple generic drugs in 2023. |
| Sun Pharmaceutical Industries Limited | Approved | Yes | Yes | 10 (January 2023 to September 2023) | Entered licensing agreement with Pharmazz Inc. in September 2023. |
| Ind-Swift Laboratories Limited | Approved | Yes | Yes | Not specified | Received EU GMP compliance from Hungary in November 2025. |
| Alkem Laboratories Limited | Approved | Yes | Yes | 9 (January 2023 to September 2023) | Received FDA approval for multiple generic drugs in 2023. |
TransData Nexus reviewed the regulatory standing of 8 leading Loratadine exporters from India. 8 hold US FDA facility approvals, 8 maintain WHO-GMP certification, and 8 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Loratadine sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," is a major hub for the production of Active Pharmaceutical Ingredients (APIs). The city hosts numerous pharmaceutical companies specializing in the synthesis of APIs, which are essential components in drug formulations. This concentration of API manufacturers provides a robust supply chain for companies producing finished dosage forms of medications like Loratadine.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. This region is home to several leading pharmaceutical companies that specialize in the development and production of finished dosage forms. The presence of a well-established infrastructure and a skilled workforce makes this cluster a key player in the manufacturing of generic medications, including Loratadine.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad region serves as a critical export gateway for India's pharmaceutical products. With its proximity to major ports and international shipping routes, this cluster facilitates the efficient export of pharmaceuticals to global markets. Companies operating in this area benefit from streamlined logistics and regulatory support, enhancing their ability to distribute products like Loratadine worldwide.
4Baddi-Nalagarh — Tax Incentive Zone
The Baddi-Nalagarh region in Himachal Pradesh has emerged as a significant pharmaceutical manufacturing zone, largely due to favorable tax incentives offered by the government. These incentives have attracted numerous pharmaceutical companies to set up manufacturing units in the area, contributing to the production capacity for various drugs, including Loratadine.
5Sourcing Recommendations
- Diversify Supplier Base: To mitigate risks associated with supply chain disruptions, consider sourcing Loratadine from multiple manufacturers across different pharmaceutical clusters in India.
- Evaluate Supplier Capabilities: Assess the manufacturing capabilities and quality standards of potential suppliers, focusing on their experience in producing antihistamines and compliance with international regulatory requirements.
- Leverage Export Infrastructure: Utilize suppliers located in export-centric regions like Mumbai-Thane-Raigad to benefit from efficient logistics and reduced lead times for international shipments.
- Monitor Regulatory Compliance: Ensure that selected suppliers adhere to the guidelines set forth by regulatory bodies such as the Central Drugs Standard Control Organisation (CDSCO) and the Directorate General of Foreign Trade (DGFT) to maintain product quality and compliance.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Loratadine exporters from India
Aurobindo Pharma Limited — Aurobindo Pharma acquires Khandelwal Laboratories' business
Aurobindo Pharma Limited, through its wholly owned subsidiary Auro Pharma Limited, acquired the business of Khandelwal Laboratories Private Limited as a going concern on a slump sale basis, effective January 1, 2026. The acquisition, valued at INR 3,250 million, adds brands in pain management and anti-infective segments to Aurobindo's portfolio. - IMPACT: This acquisition is expected to enhance Aurobindo's domestic market presence, potentially influencing its Loratadine export capabilities.
Impact: This acquisition is expected to enhance Aurobindo's domestic market presence, potentially influencing its Loratadine export capabilities.
Marksans Pharma Limited — Marksans Pharma incorporates subsidiaries in Ireland and Canada
Marksans Pharma Limited incorporated two wholly owned subsidiaries: Marksans Pharma (Europe) Limited in Ireland and Marksans (Canada) Inc. in Canada, both aimed at conducting pharmaceutical business in their respective regions. - IMPACT: These expansions may bolster Marksans Pharma's global distribution network, potentially affecting Loratadine export volumes.
Impact: These expansions may bolster Marksans Pharma's global distribution network, potentially affecting Loratadine export volumes.
Aurobindo Pharma Limited — Aurobindo Pharma acquires Veritaz Healthcare's business
Aurobindo Pharma Limited acquired the business of Veritaz Healthcare Limited, including certain assets, for a total consideration of approximately INR 1,710 million, effective April 1, 2022. - IMPACT: This acquisition is likely to strengthen Aurobindo's product portfolio, potentially impacting Loratadine exports.
Impact: This acquisition is likely to strengthen Aurobindo's product portfolio, potentially impacting Loratadine exports.
Common Questions — Loratadine Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which loratadine supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, SANDOZ PRIVATE LIMITED leads with 89 recorded shipments worth $105.1M. AUROBINDO PHARMA LTD (265 shipments) and MARKSANS PHARMA LIMITED (339 shipments) are also established high-volume exporters.
Q How many loratadine manufacturers are there in India?
India has 347 active loratadine exporters with a combined export market of $173.1M across 4,321 shipments to 131 countries. The top 5 suppliers hold 76.4% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for loratadine from India?
Average FOB unit price: $3.04 per unit, ranging from $0.00 to $1303.59. Average shipment value: $40.1K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 347 verified Indian exporters of Loratadine ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 4,321 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 131 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
4,321 Verified Shipments
347 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists